Methods, compositions, and formulations for the treatment of thyroid eye disease

Details for Australian Patent Application No. 2007313077 (hide)

Owner Lithera, Inc.

Inventors Dobak, John Daniel

Agent Shelston IP

Pub. Number AU-B-2007313077

PCT Pub. Number WO2008/048770

Priority 60/919,011 20.03.07 US; 60/898,009 29.01.07 US; 60/852,221 17.10.06 US

Filing date 27 September 2007

Wipo publication date 24 April 2008

Acceptance publication date 2 June 2011

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/048770 Priority application(s): WO2008/048770

2 July 2009 Alteration of Name

  The name of the applicant has been altered to Lithera, Inc.

2 June 2011 Application Accepted

  Published as AU-B-2007313077

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313086-Orthopedic revision connector

2007313072-Improved depolluting coating composition